Reimbursement Submissions
(PBAC, MSAC, LSDP, PL)
Our expertise includes:
- Health Technology Assessments (HTA)
- PBAC Submissions
- MSAC Submissions
- PHARMAC Submissions
- Prescribed List (formerly known as the Prosthesis List) Applications
- Hospital Formulary Submissions:
– Pricing and Reimbursement Strategy
– Risk Sharing Agreements
– Post-Market Analyses
– Price/Volume Impact Analyses
– Reimbursement Feasibility Studies
Let us help you navigate the complexities of the Australian reimbursement landscape and achieve your market access goals.
Get in touch with us today to discover how we can help your pharmaceuticals, biotech products, medical devices, and technologies successfully enter the Australian market.
Lucid Health Consulting are providers of expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia. Enabling companies to optimise the entry of their pharmaceutical, biotech and medical devices into the Australian market.